Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Phase 3: Dual Improvement (Weeks 8 through 16) This is the most productive phase of the protocol
Gently press into face and neck
(Stimulated Egr-1 gene, NAB2, FAK-paxillin and JAK-2 pathways) BPC-157 Uses ORAL: 250-500 mcg by mouth daily in 1-2 divided doses SUBQ: 250-500mcg subcutaneously once-twice daily INTRAMUSCULAR: 250-500mcg as close to the site of injury as possible QD-BID SUBLINGUAL: 200-500 mcg between cheek and gum daily in 1-2 divided doses BPC-157 used to treat injuries We will use the ACL tendon in the knee as an example for this article
org/10.1016/bs.vh.2022.09.002 Giustarini, D., Milzani, A., Dalle-Donne, I
Stay informed
US$ 23.12
US$ 26.23
US$ 25.00
US$ 20.71
US$ 25.84
US$ 24.82
